Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.

Saved in:
Bibliographic Details
Title: Phase I studies assessing safety and pharmacokinetics of nacubactam administered alone or in combination with cefepime or aztreonam in Japanese healthy participants.
Authors: Morita J; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Hida N; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Setagaya-ku, Tokyo, Japan.; SHOWA Medical University Clinical Research Institute for Clinical Pharmacology and Therapeutics, Setagaya-ku, Tokyo, Japan., Yonemura T; Souseikai Sumida Hospital, Tokyo, Japan., Yamazaki T; Department of Clinical Research and Development, Graduate School of Pharmacy, Showa Medical University, Setagaya-ku, Tokyo, Japan.; SHOWA Medical University Clinical Research Institute for Clinical Pharmacology and Therapeutics, Setagaya-ku, Tokyo, Japan., Sato H; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Sumiya M; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Takaya R; R & D Division, Meiji Seika Pharma Co., Ltd., Chuo-ku, Tokyo, Japan., Kumagai Y; Kitasato University Kitasato Institute Hospital, Minato-ku, Tokyo, Japan., Uchida N; Department of Clinical Pharmacology, Graduate School of Medicine, SHOWA Medical University, Setagaya-ku, Tokyo, Japan.
Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2026 May 06; Vol. 70 (5), pp. e0177025. Date of Electronic Publication: 2026 Apr 13.
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-6596
DOI:10.1128/aac.01770-25